Lin Lü

1.9k total citations
138 papers, 1.3k citations indexed

About

Lin Lü is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lin Lü has authored 138 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Endocrinology, Diabetes and Metabolism, 52 papers in Surgery and 32 papers in Molecular Biology. Recurrent topics in Lin Lü's work include Pituitary Gland Disorders and Treatments (62 papers), Adrenal and Paraganglionic Tumors (38 papers) and Growth Hormone and Insulin-like Growth Factors (28 papers). Lin Lü is often cited by papers focused on Pituitary Gland Disorders and Treatments (62 papers), Adrenal and Paraganglionic Tumors (38 papers) and Growth Hormone and Insulin-like Growth Factors (28 papers). Lin Lü collaborates with scholars based in China, United States and United Kingdom. Lin Lü's co-authors include Yong Yao, Huijuan Zhu, Renzhi Wang, Song Chen, Zhang Py, Mingming Liu, Kan Deng, Zhaolin Lu, Ming Feng and Bing Xing and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The FASEB Journal and Endocrinology.

In The Last Decade

Lin Lü

121 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Lü China 17 663 356 277 202 150 138 1.3k
Hye In Kim South Korea 19 765 1.2× 488 1.4× 407 1.5× 177 0.9× 86 0.6× 44 1.5k
Marina Κita Greece 28 892 1.3× 435 1.2× 307 1.1× 205 1.0× 44 0.3× 78 2.2k
Michiaki Abe Japan 20 336 0.5× 446 1.3× 310 1.1× 131 0.6× 87 0.6× 82 1.8k
Shyang‐Rong Shih Taiwan 20 621 0.9× 203 0.6× 370 1.3× 177 0.9× 43 0.3× 74 1.5k
Clinton C. Mason United States 19 356 0.5× 221 0.6× 363 1.3× 73 0.4× 142 0.9× 42 1.2k
Hennie G. Raterman Netherlands 22 180 0.3× 168 0.5× 367 1.3× 120 0.6× 72 0.5× 40 1.5k
Yoshihito Atsumi Japan 22 608 0.9× 220 0.6× 324 1.2× 131 0.6× 23 0.2× 63 1.2k
Diethelm Tschöpe Germany 23 640 1.0× 323 0.9× 255 0.9× 118 0.6× 108 0.7× 85 1.9k
Julie Dubourg France 16 516 0.8× 417 1.2× 327 1.2× 672 3.3× 53 0.4× 35 1.5k
Wenjia Yang China 18 642 1.0× 240 0.7× 310 1.1× 99 0.5× 21 0.1× 59 1.1k

Countries citing papers authored by Lin Lü

Since Specialization
Citations

This map shows the geographic impact of Lin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lü more than expected).

Fields of papers citing papers by Lin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lü. The network helps show where Lin Lü may publish in the future.

Co-authorship network of co-authors of Lin Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Lü. A scholar is included among the top collaborators of Lin Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Lü. Lin Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Xinxin, Yong Yao, Kan Deng, et al.. (2025). Silent growth hormone pituitary adenomas: a single-center study. Pituitary. 28(5). 99–99.
2.
Zhang, Weizheng, Xiangsheng Cai, Lin Lü, et al.. (2025). A study on the correlation between hyperuricemia and lifestyle and dietary habits. Medicine. 104(5). e41399–e41399. 1 indexed citations
4.
Cui, Yunying, et al.. (2024). Pheochromocytoma in von Hippel‐Lindau Disease: Clinical Features and Comparison With Sporadic Pheochromocytoma. Clinical Endocrinology. 102(3). 355–361.
5.
Yang, Jun, et al.. (2024). A Stepwise Approach to Surgical Decision-making for Lower Eyelid Ectropion: Insights from a Retrospective Study. Aesthetic Surgery Journal. 45(4). 341–346.
6.
Gao, Yinjie, Lin Lü, Anli Tong, et al.. (2023). The underlying cause of the simple virilizing phenotype in patients with 21-hydroxylase deficiency harboring P31L variant. Frontiers in Endocrinology. 13. 1015773–1015773. 4 indexed citations
7.
Sun, Xu, Yijun Wu, Lin Lü, et al.. (2023). Bone Microarchitecture and Volumetric Mineral Density Assessed by HR-pQCT in Patients with 21- and 17α-Hydroxylase Deficiency. Calcified Tissue International. 113(5). 515–525. 2 indexed citations
8.
Wang, Yawen, Lian Duan, Yong Yao, et al.. (2023). Diagnosis and Management of Idiopathic Hypothalamic Dysfunction: A Case Series and Systematic Review. Neuroendocrinology. 113(5). 479–488.
9.
Zhang, Dingyue, et al.. (2023). Machine learning models for differential diagnosis of Cushing’s disease and ectopic ACTH secretion syndrome. Endocrine. 80(3). 639–646. 7 indexed citations
10.
Ben-Shlomo, Anat, John D. Carmichael, Christina Wang, et al.. (2022). Treatment of Cushing Disease With Pituitary-Targeting Seliciclib. The Journal of Clinical Endocrinology & Metabolism. 108(3). 726–735. 16 indexed citations
11.
Lü, Lin, Huijuan Zhu, Yu Xiao, et al.. (2022). Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature. International Journal of Endocrinology. 2022. 1–10. 1 indexed citations
12.
Duan, Lian, Shi Chen, Lin Lü, et al.. (2022). Pituicytoma Associated with Suspected Cushing’s Disease: Two Case Reports and a Literature Review. Journal of Clinical Medicine. 11(16). 4805–4805. 3 indexed citations
13.
He, Wang, Shanshan Feng, Yifan Liu, et al.. (2021). Diagnosis, Manifestations, Laboratory Investigations, and Prognosis in Pediatric and Adult Cushing’s Disease in a Large Center in China. Frontiers in Endocrinology. 12. 749246–749246. 4 indexed citations
14.
Lü, Lin, Ling Li, Yining Wang, et al.. (2021). Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review. Frontiers in Cardiovascular Medicine. 8. 777964–777964. 5 indexed citations
15.
Zhu, Jianyu, Yi Zhang, Jie Liu, et al.. (2020). Ectopic pituitary adenomas: clinical features, diagnostic challenges and management. Pituitary. 23(6). 648–664. 18 indexed citations
16.
Zhu, Jianyu, Yi Zhang, Jie Liu, et al.. (2020). Suprasellar pituitary adenomas: a 10-year experience in a single tertiary medical center and a literature review. Pituitary. 23(4). 367–380. 9 indexed citations
17.
Lü, Lin, et al.. (2020). A General Outpatient Triage System Based on Dynamic Uncertain Causality Graph. IEEE Access. 8. 93249–93263. 8 indexed citations
18.
Liu, Yang, Linjie Wang, Wen Zhang, et al.. (2018). Hypophyseal Involvement in Immunoglobulin G4-Related Disease: A Retrospective Study from a Single Tertiary Center. International Journal of Endocrinology. 2018. 1–9. 13 indexed citations
19.
Zhang, Yi, Yue Teng, Huijuan Zhu, et al.. (2018). Granular Cell Tumor of the Neurohypophysis: 3 Cases and a Systematic Literature Review of 98 Cases. World Neurosurgery. 118. e621–e630. 18 indexed citations
20.
Pan, Bo, et al.. (2007). Inhibitory effects of resistin-13-peptide on the proliferation, adhesion, and invasion of MDA-MB-231 in human breast carcinoma cells. Endocrine Related Cancer. 14(4). 1063–1071. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026